This article discusses a feasibility trial investigating the combination of Varenicline and oral nicotine replacement therapy (NRT) with smartphone-based medication reminders to support smoking cessation.
The study aims to evaluate whether this integrated approach can improve medication adherence and quit rates among smokers seeking to quit.